Extracorporeal Shockwave Therapy for Diabetic Foot Wounds
Launched by HULL UNIVERSITY TEACHING HOSPITALS NHS TRUST · Jul 31, 2019
Trial Information
Current as of July 21, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Diagnosis of diabetes mellitus
- • Open wound of the foot
- • ABPI \>0.8
- • Age greater than 18 years old
- • Able and willing to give written informed consent
- • Be able to adhere to protocol and attend all follow up appointments
- Exclusion Criteria:
- • Pregnancy or breast-feeding
- • Current malignancy
- • Allergy to materials used in the treatment
- • Palliative
- • Unable or unwilling to give consent
- • Anticoagulation
About Hull University Teaching Hospitals Nhs Trust
Hull University Teaching Hospitals NHS Trust is a leading healthcare organization dedicated to delivering high-quality patient care, education, and research. Located in Hull, England, the Trust encompasses a range of hospitals and healthcare services, providing a comprehensive spectrum of clinical specialties. With a strong commitment to advancing medical science, the Trust actively sponsors and conducts clinical trials that aim to improve patient outcomes and contribute to evidence-based practice. By collaborating with academic partners and leveraging its state-of-the-art facilities, Hull University Teaching Hospitals NHS Trust fosters an innovative research environment that prioritizes patient safety and ethical standards.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hull, , United Kingdom
Patients applied
Trial Officials
George E Smith, M.D
Principal Investigator
Academic Vascular Surgery Unit
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials